An interventional study of Activa BioACTIVE Bulk Flow and Filtek Z250 in Dental Caries, sponsored by Bezmialem Vakif University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Bezmialem Vakif University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 130 studies in Dental Caries with a site in Turkey — 24 open to participants now, 40 under way, none of them phase 3. Dental Caries · Turkey.
Among the 130 studies in Dental Caries with a site in Turkey, this one is the 79th largest by planned enrollment of the 94 interventional ones that give a count, is one of 15 that started in 2026, is one of 91 with no phase, reaches primary completion later than 36 of the 39 other live ones, and was the 109th registered.
1,176 studies on the registry are indexed under Dental Caries; 209 are open to participants now.
Browse Dental Caries studies →24 of the 130 studies in Dental Caries with a site in Turkey are open now. Recruiting first, the newest first:
Alanya Alaaddin Keykubat University · Sites in Turkey
Ages 7–12 · Healthy volunteers
Neslihan Atmaca · Sites in Turkey
Ages 6–14
Gül Keskin · Sites in Turkey
Ages 6–8 · Healthy volunteers
Çanakkale Onsekiz Mart University · Sites in Turkey
Ages 4–9 · Healthy volunteers
Çanakkale Onsekiz Mart University · Sites in Turkey
Ages 7–12 · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.
This study: 18 Years to 50 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
130 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 15 started in 2026.
This study's planned enrollment of 34 is below the median of 60 across 967 interventional studies indexed under Dental Caries.
Median enrollment 60 across the 94 interventional studies, 85 across the 36 observational. Of the 80 that completed or were terminated, 1 (1%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 130 has an industry lead sponsor. The 10 most frequent:
Bezmialem Vakif University is the lead sponsor of 359 studies on the registry; 61 are open to participants now.
Bezmialem Vakif University has 8 studies filed under Dental Caries — fewer than ten, so there is no comparison to draw.
12 of the studies in Dental Caries with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07431463Izmir Katip Celebi UniversityEffects of Different Remineralization Agents on the Progression of Non-Cavitated Approximal Carious Lesions in Primary Teeth: A Randomized Clinical Trial | 2026-11-30 |
| NCT07673952Hacettepe UniversityEffect on Placement Tecnique of Bulkfill Composite | 2027-01-01 |
| NCT07609797Gül KeskinThe Effects of Sodium Fluoride and Chlorhexidine Use on Salivary IL-6 and Matrix Metalloproteinase Levels in Children With Active Caries | 2027-01-01 |
| NCT07548008Marmara UniversityFerric Sulfate and Sodium Hypochlorite Pulpotomies in Vital Primary Teeth | 2027-02-10 |
| NCT07611981Alanya Alaaddin Keykubat UniversityDental Caries and Oral Hygiene Status in Children With Specific Learning Disabilities | 2027-04 |
Add all 12 to your calendar (.ics) → With an account.
Among the 130 studies in Dental Caries with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective split-mouth clinical study aims to compare the clinical performance of a bioactive bulk-fill composite with a conventional microhybrid composite in Class II posterior restorations. In each participant, two comparable Class II cavities will be treated using different restorative approaches. In the experimental condition, a bioactive bulk-fill composite (Activa BioACTIVE Bulk Flow) will be placed at the gingival base and covered with a microhybrid composite (Filtek Z250). In the control condition, restorations will be completed entirely with the microhybrid composite (Filtek Z250).
Clinical performance will be evaluated according to FDI World Dental Federation criteria at baseline, 6 months, and 12 months. Primary outcomes include marginal adaptation, retention, and overall clinical success of the restorations. Secondary outcomes include surface properties and marginal staining.
The split-mouth design allows direct intra-individual comparison, thereby minimizing inter-individual variability and increasing the reliability of the findings. The results of this study are expected to provide evidence on the effectiveness of bioactive bulk-fill composites in improving the clinical performance of posterior restorations.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Bioactive bulk-fill composite (Activa BioACTIVE Bulk Flow) applied at the gingival base and covered with microhybrid composite (Filtek Z250).
Device: Activa BioACTIVE Bulk Flow
Restorations performed entirely using microhybrid composite (Filtek Z250).
Device: Filtek Z250
Bioactive bulk-fill composite material used at the gingival base in Class II restorations.
Conventional microhybrid composite used for full restoration in Class II cavities.
Clinical performance of restorations (FDI criteria)
Evaluation of restorations according to FDI criteria including marginal adaptation, retention, and overall clinical success.
Time frame: Baseline, 6 months, and 12 months
Marginal discoloration and surface properties
Assessment of marginal staining and surface characteristics of restorations based on FDI criteria.
Time frame: Baseline, 6 months, and 12 months
Started Feb 2026 (actual). Primary completion is estimated for Nov 2027, 21 months after the start.
Of 470 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 21 months is above that.
Counting every sponsor, half of 503 studies reached it within 15 months; a quarter within 7 and three quarters within 29.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 17, 2026: primary completion Jun 2027 → Nov 2027 and completion Aug 2027 → Jan 2028.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.